-
Eyegate Pharmaceuticals Spikes 12%; Co. Eligible To Receive Milestone Payment From Valeant
Wednesday, March 2, 2016 - 12:47pm | 192Read More...Shares of Eyegate Pharmaceuticals Inc (NASDAQ: EYEG), a nano-cap clinical-stage specialty pharmaceutical company that focuses on treatment for diseases of the eye, gained more than 12 percent on Wednesday. Eyegate announced that it has received an additional development milestone from Valeant...
